CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

not applicable (observational study)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug3335 mechanical ventilator settings and position Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Registry of Biological Samples, Clinical Information and Epidemiological Data of COVID-19 Patients Admitted at the University Hospital of Verona (AOUI Verona)

The registry of COVID-19 patients was designed to collect epidemiolgical, demographic, clinical, anamnestic and outcome information together with serological and microbiological samples from COVID-19 patients admitted at the University Hospital of Verona (Azienda Ospedaliera Universitaria Integrata, AOUI Verona). All SARS-CoV 2 positive patients admitted and able to give an informed consent are included, irrespectively of age and gender.

NCT04497194 Coronavirus Disease 2019 Other: not applicable (observational study)
MeSH:Coronavirus Infections

Primary Outcomes

Description: Epidemiological data including demographic data, contact with COVD-19 positive patients and onset of symptoms.

Measure: Epidemiological predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Underlying chronic diseases, signs/symptoms related with COVID-19 diseases an clinical presentation on admission

Measure: Clinical predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Body temperature (°C)

Measure: Body temperature (°C) on admission in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Blood pressure (mmHg)

Measure: Blood pressure (mmHg) on admission in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Pulse rate (beats per minute)

Measure: Pulse rate (beats per minute) on admission in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Pulse rate (beats per minute)

Measure: Respiratory rate (breaths per minute) on admission in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Peripheral oxygen saturation (%)

Measure: Peripheral oxygen saturation (%) on admission in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: CRP (m/gL)

Measure: C reactive protein (CRP, m/gL) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: PCT (ng/mL

Measure: Procalcitonin (PCT, ng/mL) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: White Blood Count (WBC, cell/mm3)

Measure: White Blood Count (WBC, cell/mm3) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Neutrophils (cell/mm3)

Measure: Neutrophils (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Lymphocytes (cell/mm3)

Measure: Lymphocytes (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Platelets (cell/mm3)

Measure: Platelets (cell/mm3) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: LDH (mU/ml)

Measure: L-lattato deidrogenasi (LDH, mU/ml) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: CK (U/L)

Measure: Creatine kinase (CK, U/L) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: D-dimer (μg/L)

Measure: D-dimer (μg/L) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: fibrinogen (g/L)

Measure: fibrinogen (g/L) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: ferritin (mcg/L)

Measure: ferritin (mcg/L) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: AST (U/L)

Measure: AST (U/L) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: ALT (U/L)

Measure: ALT (U/L) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: Creatinine (mg/dl)

Measure: Creatinine (mg/dl) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: pH

Measure: Arterial blood gas anaysis pH in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: pO2 (mmHg)

Measure: Arterial blood gas anaysis pO2 (mmHg) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: pCO2 (mmHg)

Measure: Arterial blood gas anaysis pCO2 (mmHg) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: HCO3 (mmol/l)

Measure: Arterial blood gas anaysis HCO3 (mmol/l) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: SpO2 (%)

Measure: Arterial blood gas anaysis SpO2 (%) in COVID-19 patients admitted to University Hospital of Verona

Time: through study completion, an average of 3 months

Description: IL-6 (pg/mL)

Measure: Host-related factors associated with the pathogenesis of COVID-19

Time: through study completion, an average of 3 months

Description: Nasal and rectal swabs, fecal samples and blood samples

Measure: Virological factors associated with the pathogenesis of COVID-19

Time: through study completion, an average of 3 months

No related HPO nodes (Using clinical trials)